The Effect of Caffeine Therapy in Cardiovascular Stability in Preterm Neonates at Assiut University Children Hospital NICU
NCT07274969 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2025-12-10
Summary
Preterm neonates younger than 37 weeks gestational age receiving caffeine therapy for apnea of prematurity in a NICU setting.
Conditions
- Preterm Neonates
- Apnea of Prematurity
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Max Age
- 37 Weeks
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-30
- Primary Completion
- 2027-08-30
- Completion
- 2027-12-30
More Related Trials
-
Oxygen Saturation and Caffeine Post-Discharge
NCT02386046 ·Status: TERMINATED
-
Caffeine Citrate to Improve Neonatal Outcomes.
NCT06972849 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea
NCT01911182 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Caffeine for Apnea of Prematurity (CAP)
NCT00182312 ·Status: COMPLETED ·Phase: PHASE3
-
Apnea of Prematurity Results in Respiratory Distress and Cyanosis. Caffeine Citrate Can Treat It.
NCT06905496 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Caffeine for Preterm Infants With Apnea of Prematurity(AOP)
NCT03298347 ·Status: UNKNOWN ·Phase: NA
-
Caffeine Use in the Management of Preterm Infants
NCT06327152 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Prophylactic Versus Therapeutic Caffeine for Apnea of Prematurity
NCT02677584 ·Status: COMPLETED ·Phase: NA
-
Caffeine to Reduce Mechanical Ventilation in Preterm Infants
NCT01751724 ·Status: TERMINATED ·Phase: NA
-
The Role of Electroencephalography in Caffeine Discontinuation Timing in Premature Infants
NCT07324941 ·Status: RECRUITING
-
Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress
NCT06026163 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Target Weaning Oxygen to Determine Cafffeine Duration for AOP
NCT04868565 ·Status: COMPLETED ·Phase: PHASE4
-
Early Caffeine in Preterm Neonates
NCT03086473 ·Status: UNKNOWN ·Phase: PHASE4
-
Caffeine Treatment in in the Delivery Room
NCT04044976 ·Status: COMPLETED ·Phase: NA
-
The Effect of Stimulating Substances on Brain Activity of Preterm Infants
NCT01344317 ·Status: UNKNOWN
-
Early Versus Late Caffeine for ELBW Newborns
NCT02524249 ·Status: TERMINATED ·Phase: NA
-
Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial
NCT03340727 ·Status: TERMINATED ·Phase: PHASE3
-
Intermittent Hypoxia and Caffeine in Infants Born Preterm
NCT03321734 ·Status: COMPLETED ·Phase: PHASE2
-
Management of Apnea in Late Preterm and Term Infants
NCT02408328 ·Status: WITHDRAWN ·Phase: PHASE2
-
Caffeine Citrate Use and Electronic Activity of the Diaphragm (EDI) Changes
NCT05393817 ·Status: COMPLETED
-
The Effect of an Additional Pre-extubational Loading Dose of Caffeine-citrate
NCT06401083 ·Status: RECRUITING ·Phase: PHASE4
-
Baby-CINO: CaffeINe Treatment Optimisation in Premature Infants
NCT06416956 ·Status: RECRUITING
-
Improving Preterm Kidney Outcomes With Caffeine
NCT07262060 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effects of Caffeine on Intermittent Hypoxia in Infants Born Preterm
NCT01875159 ·Status: COMPLETED ·Phase: PHASE3
-
Early NCPAP Before Surfactant Treatment in Very Preterm Infants With RDS
NCT01996670 ·Status: COMPLETED